ICU MEDICAL INC (ICUI) Stock Fundamental Analysis

NASDAQ:ICUI • US44930G1076

142.02 USD
-5.71 (-3.87%)
At close: Feb 12, 2026
142.02 USD
0 (0%)
After Hours: 2/12/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ICUI. ICUI was compared to 186 industry peers in the Health Care Equipment & Supplies industry. ICUI has only an average score on both its financial health and profitability. ICUI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ICUI was profitable.
  • In the past year ICUI had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ICUI reported negative net income in multiple years.
  • Of the past 5 years ICUI 4 years had a positive operating cash flow.
ICUI Yearly Net Income VS EBIT VS OCF VS FCFICUI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • With a decent Return On Assets value of -0.18%, ICUI is doing good in the industry, outperforming 73.12% of the companies in the same industry.
  • ICUI has a better Return On Equity (-0.35%) than 73.66% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.86%, ICUI is in the better half of the industry, outperforming 70.43% of the companies in the same industry.
  • ICUI had an Average Return On Invested Capital over the past 3 years of 1.36%. This is significantly below the industry average of 8.83%.
  • The last Return On Invested Capital (2.86%) for ICUI is above the 3 year average (1.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.18%
ROE -0.35%
ROIC 2.86%
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ICUI Yearly ROA, ROE, ROICICUI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • ICUI's Operating Margin of 5.63% is fine compared to the rest of the industry. ICUI outperforms 70.43% of its industry peers.
  • In the last couple of years the Operating Margin of ICUI has declined.
  • ICUI has a worse Gross Margin (36.47%) than 71.51% of its industry peers.
  • In the last couple of years the Gross Margin of ICUI has remained more or less at the same level.
Industry RankSector Rank
OM 5.63%
PM (TTM) N/A
GM 36.47%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
ICUI Yearly Profit, Operating, Gross MarginsICUI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • ICUI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ICUI has more shares outstanding
  • The number of shares outstanding for ICUI has been increased compared to 5 years ago.
  • ICUI has a worse debt/assets ratio than last year.
ICUI Yearly Shares OutstandingICUI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ICUI Yearly Total Debt VS Total AssetsICUI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • ICUI has an Altman-Z score of 2.19. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ICUI has a Altman-Z score of 2.19. This is in the better half of the industry: ICUI outperforms 65.59% of its industry peers.
  • ICUI has a debt to FCF ratio of 21.21. This is a negative value and a sign of low solvency as ICUI would need 21.21 years to pay back of all of its debts.
  • ICUI has a Debt to FCF ratio of 21.21. This is in the better half of the industry: ICUI outperforms 69.35% of its industry peers.
  • A Debt/Equity ratio of 0.62 indicates that ICUI is somewhat dependend on debt financing.
  • ICUI's Debt to Equity ratio of 0.62 is on the low side compared to the rest of the industry. ICUI is outperformed by 62.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 21.21
Altman-Z 2.19
ROIC/WACC0.3
WACC9.69%
ICUI Yearly LT Debt VS Equity VS FCFICUI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 2.45 indicates that ICUI has no problem at all paying its short term obligations.
  • The Current ratio of ICUI (2.45) is comparable to the rest of the industry.
  • A Quick Ratio of 1.19 indicates that ICUI should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.19, ICUI is doing worse than 67.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 1.19
ICUI Yearly Current Assets VS Current LiabilitesICUI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 40.14% over the past year.
  • The Earnings Per Share has been decreasing by -5.28% on average over the past years.
  • The Revenue has decreased by -0.84% in the past year.
  • The Revenue has been growing by 13.47% on average over the past years. This is quite good.
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-9.48%

3.2 Future

  • ICUI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.56% yearly.
  • ICUI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.95% yearly.
EPS Next Y23.37%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue Next Year-4.9%
Revenue Next 2Y-3.64%
Revenue Next 3Y-1.17%
Revenue Next 5Y2.95%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICUI Yearly Revenue VS EstimatesICUI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B 2.5B
ICUI Yearly EPS VS EstimatesICUI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.84, ICUI is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of ICUI indicates a rather cheap valuation: ICUI is cheaper than 84.95% of the companies listed in the same industry.
  • ICUI is valuated rather cheaply when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 17.31, ICUI is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ICUI indicates a rather cheap valuation: ICUI is cheaper than 84.41% of the companies listed in the same industry.
  • ICUI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.84
Fwd PE 17.31
ICUI Price Earnings VS Forward Price EarningsICUI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • ICUI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ICUI is cheaper than 83.87% of the companies in the same industry.
  • ICUI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ICUI is cheaper than 71.51% of the companies in the same industry.
Industry RankSector Rank
P/FCF 56.34
EV/EBITDA 13.57
ICUI Per share dataICUI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • ICUI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ICUI's earnings are expected to grow with 14.98% in the coming years.
PEG (NY)0.76
PEG (5Y)N/A
EPS Next 2Y14.84%
EPS Next 3Y14.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ICUI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICU MEDICAL INC

NASDAQ:ICUI (2/12/2026, 8:00:02 PM)

After market: 142.02 0 (0%)

142.02

-5.71 (-3.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06
Earnings (Next)02-19
Inst Owners118.03%
Inst Owner Change-1.15%
Ins Owners0.96%
Ins Owner Change-1.94%
Market Cap3.51B
Revenue(TTM)2.32B
Net Income(TTM)-7.36M
Analysts83.33
Price Target185.03 (30.28%)
Short Float %4.79%
Short Ratio4.93
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.05%
Min EPS beat(2)37.25%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)36.86%
Min EPS beat(4)31.74%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)33.65%
EPS beat(12)12
Avg EPS beat(12)26.3%
EPS beat(16)15
Avg EPS beat(16)20.15%
Revenue beat(2)1
Avg Revenue beat(2)0.33%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)2.43%
Revenue beat(4)3
Avg Revenue beat(4)1.47%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.09%
Revenue beat(8)6
Avg Revenue beat(8)0.95%
Revenue beat(12)6
Avg Revenue beat(12)-0.92%
Revenue beat(16)8
Avg Revenue beat(16)-0.53%
PT rev (1m)0%
PT rev (3m)4.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.69%
EPS NY rev (1m)-0.44%
EPS NY rev (3m)7.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.65%
Revenue NY rev (1m)-0.31%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 17.84
Fwd PE 17.31
P/S 1.51
P/FCF 56.34
P/OCF 21.99
P/B 1.65
P/tB N/A
EV/EBITDA 13.57
EPS(TTM)7.96
EY5.6%
EPS(NY)8.2
Fwd EY5.78%
FCF(TTM)2.52
FCFY1.77%
OCF(TTM)6.46
OCFY4.55%
SpS93.98
BVpS86.16
TBVpS-1.47
PEG (NY)0.76
PEG (5Y)N/A
Graham Number124.22
Profitability
Industry RankSector Rank
ROA -0.18%
ROE -0.35%
ROCE 3.62%
ROIC 2.86%
ROICexc 3.12%
ROICexgc 9.01%
OM 5.63%
PM (TTM) N/A
GM 36.47%
FCFM 2.68%
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 21.21
Debt/EBITDA 3.95
Cap/Depr 47.91%
Cap/Sales 4.19%
Interest Coverage 250
Cash Conversion 47.79%
Profit Quality N/A
Current Ratio 2.45
Quick Ratio 1.19
Altman-Z 2.19
F-Score7
WACC9.69%
ROIC/WACC0.3
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
EPS Next Y23.37%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-9.48%
Revenue Next Year-4.9%
Revenue Next 2Y-3.64%
Revenue Next 3Y-1.17%
Revenue Next 5Y2.95%
EBIT growth 1Y142.55%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year43.36%
EBIT Next 3Y18.75%
EBIT Next 5Y17.88%
FCF growth 1Y597.89%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y117.81%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%

ICU MEDICAL INC / ICUI FAQ

What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ICUI.


Can you provide the valuation status for ICU MEDICAL INC?

ChartMill assigns a valuation rating of 6 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.


What is the profitability of ICUI stock?

ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.


Can you provide the financial health for ICUI stock?

The financial health rating of ICU MEDICAL INC (ICUI) is 4 / 10.


What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?

The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 23.37% in the next year.